← Catalyst calendarBBNX biotech catalysts & pipeline
BETA BIONICS INC · Data as of 2026-09-08
Upcoming catalysts
iLet — Topline data
Mid 2027
In July 2026, we began enrolling adults with T2D in a pivotal trial in the United States, with the goal of expanding the iLet's indications for use to include adults with T2D around mid-year 2027, subject to regulatory clearance by the FDA.
Source filingiLet — Regulatory decision
Mid 2027
Beta Bionics expects to expand iLet's indications for use to adults with type 2 diabetes in the U.S. around mid-year 2027, subject to regulatory clearance by the FDA.
Source filingExplore the free biotech catalyst calendar